OLSO: Norway savings bank lowered its stake in shares of Johnson & Johnson (NYSE:JNJ) by 4.6% in the third quarter, according to its most recent disclosure with the securities & exchange commission. The firm owned 15,701 shares of the company’s stock after selling 755 shares during the quarter. Johnson & Johnson comprises 2.0% of Norway Savings Bank’s portfolio, making the stock its 13th largest holding. Norway Savings Bank’s holdings in Johnson & Johnson were worth $2,041,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also modified their holdings of the company. Pachira Investments Inc. grew its holdings in shares of Johnson & Johnson by 12.2% during the first quarter. Pachira Investments Inc. now owns 4,424 shares of the company’s stock worth $551,000 after purchasing an additional 480 shares during the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI boosted its holdings in Johnson & Johnson by 0.5% in the first quarter.
Schaper Benz & Wise Investment Counsel Inc. A number of equities analysts have issued reports on JNJ shares. Cowen restated an “outperform” rating and set a $155.00 target price (up previously from $147.00) on shares of Johnson & Johnson in a report on Wednesday, October 18th. UBS Group reaffirmed a “buy” rating and set a $148.00 price target on shares of Johnson & Johnson in a research report on Thursday, August 31st. Jefferies Group raised their price target on Johnson & Johnson from $157.00 to $160.00 and gave the stock a “buy” rating in a research report on Monday, October 16th. Zacks Investment Research raised Johnson & Johnson from a “sell” rating to a “hold” rating in a research report on Wednesday, October 4th. Finally, Credit Suisse Group set a $154.00 price target on Johnson & Johnson and gave the stock an “outperform” rating in a research report on Thursday, October 19th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and eleven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $145.47.
